Osaic Holdings’s Acurx Pharmaceuticals ACXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.75K | Buy |
540
+61
| +13% | +$988 | ﹤0.01% | 5846 |
|
|
2025
Q1 | $3.74K | Sell |
479
-107
| -18% | -$835 | ﹤0.01% | 6224 |
|
|
2024
Q4 | $9.5K | Sell |
586
-125
| -18% | -$2.03K | ﹤0.01% | 5771 |
|
|
2024
Q3 | $27K | Sell |
711
-50
| -7% | -$1.9K | ﹤0.01% | 5144 |
|
|
2024
Q2 | $34.2K | Sell |
761
-2,102
| -73% | -$94.5K | ﹤0.01% | 4942 |
|
|
2024
Q1 | $140K | Hold |
2,863
| – | – | ﹤0.01% | 3978 |
|
|
2023
Q4 | $219K | Buy |
2,863
+1,563
| +120% | +$120K | ﹤0.01% | 3847 |
|
|
2023
Q3 | $39K | Buy |
1,300
+200
| +18% | +$6K | ﹤0.01% | 5153 |
|
|
2023
Q2 | $58.3K | Buy |
1,100
+300
| +38% | +$15.9K | ﹤0.01% | 4832 |
|
|
2023
Q1 | $55.4K | Buy |
800
+200
| +33% | +$13.8K | ﹤0.01% | 4872 |
|
|
2022
Q4 | $48K | Hold |
600
| – | – | ﹤0.01% | 4955 |
|
|
2022
Q3 | $36K | Buy |
600
+50
| +9% | +$3K | ﹤0.01% | 5128 |
|
|
2022
Q2 | $42K | Buy |
+550
| New | +$42K | ﹤0.01% | 5074 |
|
|
2022
Q1 | – | Sell |
-250
| Closed | -$22K | – | 7006 |
|
|
2021
Q4 | $22K | Buy |
250
+100
| +67% | +$8.8K | ﹤0.01% | 5691 |
|
|
2021
Q3 | $15K | Buy |
+150
| New | +$15K | ﹤0.01% | 5927 |
|